Image

Locomotion Strategies of Low Back Pain Patients in a Dynamic Environment

Recruiting
18 - 65 years of age
Both
Phase N/A

Powered by AI

Overview

The biomechanical parameters studied in non-specific chronic low back pain patients in a locomotion task have so far focused on straight line walking. Although locomotion is primarily an automated action composed of repetitive patterns allowing movement from one place to another, walkers must respond to the environmental demands.These modifications show a flexible and adaptive approach to the constraints of the environment. In this study, the investigators are particularly interested in a task of crossing between two pedestrians, which is a standardised task that has shown its interest in the study of perceptual-motor co-ordination. In particular, it allows to study the mutual adaptation of speed and orientation between the two walkers.

Eligibility

Inclusion Criteria Non Specific Chronic Low Back Pain patients:

  • Participants must have pain located between the thoracolumbar hinge and the lower gluteal fold, with or without pain in either leg.
  • This pain must have been present for more than 12 weeks, on a daily or almost daily basis (at least 4 days out of 7)
  • Participants must not be on any treatment or have been on stable analgesic treatment for at least 2 weeks prior to inclusion
  • Participants must speak, read and understand French
  • Participants must be between 18 and 65 years of age
  • Participants must be able to understand simple commands and experimental instructions
  • Participants must have normal or corrected vision
  • Participants must have given informed consent to participate in the study
  • Participants must be enrolled in or receiving social security benefits

Exclusion Criteria Non Specific Chronic Low Back Pain patients:

  • Participants must not be pregnant or nursing mothers.
  • Participants must not have cognitive or psychological impairments that are incompatible with compliance and/or understanding of the protocol
  • Participants must not be unable to understand informed consent, or be under guardianship or conservatorship Subjects must not already be participating in another research protocol involving the human subject or in parallel
  • Participants must not be persons deprived of liberty by judicial or administrative decision
  • Participants must not be under psychiatric care
  • The participants must not present neurological signs evoking a neurodegenerative disease responsible for walking disorders (parkinsonian syndrome, ...)
  • The participants must not present warning signs (red flags) pointing to an underlying pathology requiring specific and/or urgent care such as
  • Ongoing litigation following a work-related accident
  • Pain related to a cancer diagnosis
  • Associated spinal cord symptoms (pyramidal signs, coordination disorders, motor or sensory deficits, sphincter disorders, etc.)
  • Pain following an infection (night sweats, fever, chills, intravenous drug abuse, immunodeficiency, recent surgery, urinary or skin infection, etc.)
  • Recent or pathological fractures (traffic accidents, history of osteoporosis, chronic use of corticosteroids, advanced age, unexplained weight loss, fatigue, history of cancer, etc. )
  • Vascular problems (cold feet, decreased peripheral arterial pulse, etc.)

Inclusion and Exclusion Criteria of control group :

        Participants strictly meet the same inclusion and non-inclusion criteria as NSCLBP
        patients, but must not have ongoing chronic pain or a history of significant chronic pain
        (≥ 4/10 for at least 6 months). They are matched for age and gender. They must not have any
        pathologies that affect walking or posture. These individuals must be able to perform the
        studied movements without the appearance of discomfort or exaggerated fatigue.

Study details

Chronic Low-back Pain, Walking

NCT05851118

University of Rennes 2

27 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.